The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is now accepting applications for our 2021 KL2 Scholars Program. The pre-application is due January 31, 2021 with the final application due February 28, 2021. Funding is expected to begin in June 2021 pending the evolution of the COVID-19 pandemic.

During our first ten years, we have been privileged to award KL2 support to 18 junior faculty colleagues from Georgetown and Howard Universities and from MedStar Health, who have leveraged this opportunity in order to publish >500 peer-reviewed manuscripts, receive over 50 extramural grants and conduct 30 sponsored clinical trials.

This K-series career development award is nearly identical to our previous KL2 awards and analogous to individual K23, K08, or K01 awards, with a focus on developing early-career (MD or equivalent; doctorally-trained nurses, pharmacists or dentists; and clinically or translationally-oriented PhD) faculty investigators through an inter- or multi-disciplinary mentored research experience so that they can become independent, extramurally-funded investigators. Given the goals of the GHUCCTS, awards will favor those: 1) who propose novel trans-, inter-, or multi-disciplinary and collaborative/team research projects, 2) from the entire T1-T4 translational continuum, 3) which span departments, disciplines, and institutions, and 4) address significant health disparities.

For more details, including application instructions, visit our KL2 Scholars page or download the RFA announcement.